Fosun International LTD Arrowhead Pharmaceuticals, Inc. Transaction History

Fosun International LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$17.43 - $28.82 $522,900 - $864,600	-30,000 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$12.05 - $20.18 $192,800 - $322,880	-16,000 Reduced 34.78%	30,000 $543,000
Q4 2018 Jan 31, 2019	BUY	$10.74 - $19.7 $494,040 - $906,200	46,000 New	46,000 $551,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.76B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.